BD Launches First Pharma-Sponsored Clinical Trial Featuring BD Libertas™ Wearable Injector for Biologics
BD (Becton, Dickinson and Company), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics. The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clinical
